| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.0M | — | +12.7% |
| Cost of Revenue | $5.2M | — | +10.7% |
| Gross Profit | $16.8M | — | +13.3% |
| R&D Expense | $956K | — | +53.1% |
| SG&A Expense | $4.6M | — | -0.9% |
| Operating Income | $7.2M | — | +33.2% |
| Pre-tax Income | $7.8M | — | +30.7% |
| Income Tax | $2.0M | — | +55.1% |
| Net Income | $5.8M | — | +24.1% |
| EPS (Basic) | $0.46 | — | +24.3% |
| EPS (Diluted) | $0.45 | — | +21.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $56.4M | +10.2% | +12.0% |
| Accounts Receivable | $13.4M | -1.8% | +5.6% |
| Inventory | $11.9M | +2.3% | +12.6% |
| Current Assets | $86.4M | +6.4% | +15.0% |
| Total Assets | $114.4M | +5.2% | +12.4% |
| Current Liabilities | $12.1M | +19.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $8.3M | — | +93.1% |
| Capital Expenditures | $403K | — | -89.1% |
| Investing Cash Flow | -$469K | — | +88.0% |
| Financing Cash Flow | -$2.6M | — | -14.4% |
| Free Cash Flow | $7.9M | — | +1226.4% |
| +43.0% |
| Total Liabilities | $15.9M | +12.1% | +36.0% |
| Stockholders' Equity | $98.5M | +4.1% | +9.4% |